Press Releases

May 7, 2020

Valneva Reports Q1 Results and Updates 2020 Guidance Following Major Lyme Partnering Deal

May 5, 2020

Valneva to Partner with Instituto Butantan on Single-Shot Chikungunya Vaccine for Low- and Middle-Income Countries

April 30, 2020

Valneva and Pfizer Announce Collaboration to Co-Develop and Commercialize Lyme Disease Vaccine, VLA15

April 22, 2020

Valneva and Dynavax Announce Collaboration to Advance Vaccine Development for COVID-19

March 31, 2020

Valneva Announces the Publication of its 2019 Universal Registration Document

March 25, 2020

Valneva Reports Positive End-of-Phase 2 Chikungunya Meeting with the U.S. FDA; Sets Stage for Phase 3 Study

March 24, 2020

Valneva Provides Business Update on COVID-19 Situation

March 8, 2020

Valneva Announces FDA Approval of IXIARO® Shelf Life Extension to 36 Months; New US Military RFP Issued

February 27, 2020

Valneva Reports Record Product Sales and Major Pipeline Progress in 2019

February 3, 2020

Valneva Announces New $85 Million Financing Arrangement with Leading US Healthcare Funds Deerfield and OrbiMed

1
2
3
4
…
34